Natural History and Pathogenesis of Alopecia in Children and Adults

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

39 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-19

Study Completion Date

2025-01-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

Alopecia is the loss of hair or lack of hair growth. It is often related to an immune disorder that disrupts the growth of hair. Hair loss can affect a person s physical and mental health. The causes of alopecia are not well understood. This natural history study will examine causes of alopecia so better treatments can be developed.

Objective:

To learn why some people have alopecia. This study will look at factors related to genes, the immune system, and the bacteria, viruses, and fungi that live on the skin.

Eligibility:

People aged 2 years and older with immune-mediated alopecia that affects 50% of their scalp hair.

Design:

Participants will have at least 1 visit to the clinic. Some will have follow-up visits once a year for up to 5 years. Each visit will last 2 to 4 hours.

Participants will have a physical exam. They will have blood drawn from a vein. They will answer questions about the medications they take, their allergies, and their family history. Photographs of their skin and scalp will be taken. Soft cotton swabs will be rubbed on their skin to pick up organisms that live there.

Two pieces of skin from the scalp will be cut away. The pieces will be no more than a quarter of an inch in size. The area will first be numbed with an injectable anesthetic. The wound will be closed with stitches or gel foam. The biopsy is optional in children younger than 12.

Participants will take a questionnaire about how hair loss affects their quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors

NCT05588310

Alopecia Areata

UNKNOWN

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

NCT05098600

Alopecia Areata Alopecia Totalis Alopecia Universalis +24 more

COMPLETED

Pharmacogenomic Study of Androgenetic Alopecia

NCT01227031

Androgenetic Alopecia

UNKNOWN

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

NCT04011748

Alopecia Areata Alopecia Totalis Alopecia Universalis

UNKNOWN PHASE2

Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia

NCT06854432

Alopecia, Androgenetic Healthy

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Description:

This is a study to detail the characteristics (genetic, immunologic, biological and demographic) of individuals who present in childhood and adulthood with alopecia and how alopecia impacts skin and systemic symptoms.

Objectives:

Primary objective: Comprehensively evaluate patients with immune mediated alopecia from clinical, microbiome, immunologic and genetic standpoint to understand the factors that contribute to clinical phenotypes.

Secondary objective: To follow patients with immune-mediated alopecia to see how disease impacts local skin microbiome, immune system changes and autoimmune and other comorbidities.

Tertiary objectives: To develop prognostic biomarkers that help predict the risk of severity and progression in patients with alopecia.

Endpoints:

1. Record demographics including age, sex, age of onset, severity of disease based on clinical examination, concomitant autoimmune disease, personal history of other medical disease including anxiety and depression, family history of autoimmune and medical disease
2. Whole genome sequencing to identify variations in the protein-coding region of any gene that may be disease causing
3. Assess peripheral blood and local scalp skin to assess immunogenicity of disease by using leukocyte subset analysis using flow cytometry, markers of disease using cytokine signaling assays, and single cell RNA sequencing
4. Define skin microbiome using sequencing at baseline and with time.
5. Identify potential biomarkers of disease progression or severity that may impact therapeutic choices

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hair Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient

Male and female ages 2-45 years old

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

1. Stated willingness to comply with study procedures including skin biopsy of the scalp (except in those under the age of 12 years) and availability for the duration of the study
2. Willing to avoid using antibacterial cleansers for 1 week prior to sampling
3. Male or female, aged 2 years and older
4. Clinical Diagnosis of immune- mediated alopecia
5. Ability of subject or Parent/legal guardian to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

1. Non-immune mediated alopecia including androgenetic alopecia, radiation induced alopecia, trauma induced alopecia, chemotherapy induced alopecia
2. Concomitant medical, surgical, or other conditions for which adequate facilities or funds are not available to support their care at the NIH.
3. Any other co-existing condition/circumstances that would make a subject unsuitable to participate in the study, as deemed by the investigators.
4. Pregnant women

Minimum Eligible Age

2 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No